MedPath

A phase 2 study of radio-chemotherapy for primary intracranial germ cell tumors

Phase 2
Recruiting
Conditions
primary intracranial germ cell tumors
Registration Number
JPRN-UMIN000004528
Lead Sponsor
Organizing Committee for a phase 2 study of radio-chemotherapy for primary intracranial germ cell tumors
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
210
Inclusion Criteria

Not provided

Exclusion Criteria

1. Previous malignancies. 2. Major renal, bladder, infectious illnesses, interstitial pneumonitis or pulmonary fibrosis, ischemic heart diseases, liver cirrhosis, bleeding, uncontrolled DM, or psychiatric impairments which in the investigator's opinion will prevent administration or completion of the protocol therapy. 3. Patients with known allergy to drugs used in the proposed regimens. 4. Patients taking warfarin. 5. patients pregnant or breast-feeding a baby. 6. Patients, in the investigator's opinion, cannot complete the protocol study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath